Endpoints: 28,729MCP servers: 18,413Payout addresses: 2,071Paid calls: 1,533Letters: 13Defects: 1,322counted 2 min ago
teppi

Endpoint · otherGETclinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29

FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results…
Read moreFDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.
UNRATEDDelisted

Overview

Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.25 per call
Paid calls
none yet
delivery unknown until someone pays

More info

Seller?
0x50ab2018…284912fc
URL
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29
Seen
first 34 days ago · last 15 days ago
53 free handshakes

Payment

Pays through
x402
Offered on?
algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, eip155:56, Base USDC, eip155:999, Solana, xrpl:0
Listed on?
Polygon, Arbitrum, Base, Solana

About

?Description
FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.
URL
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29
Method
GET
Class
other
?Checkable to
L1
Endpoint id
cap_01M1A51TG1WX3T5NM8FPDHBZEF
?Badge

Reads live. UNRATED until paid calls earn a letter.

Markdown
[![Teppi](https://api.teppi.xyz/badge/cap_01M1A51TG1WX3T5NM8FPDHBZEF.svg)](https://teppi.xyz/endpoint/cap_01M1A51TG1WX3T5NM8FPDHBZEF)
HTML
<a href="https://teppi.xyz/endpoint/cap_01M1A51TG1WX3T5NM8FPDHBZEF"><img src="https://api.teppi.xyz/badge/cap_01M1A51TG1WX3T5NM8FPDHBZEF.svg" alt="Teppi delivery record"></a>
Image
https://api.teppi.xyz/badge/cap_01M1A51TG1WX3T5NM8FPDHBZEF.svg
Verify it yourselfnpx teppi-check https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29curl -s https://api.teppi.xyz/v1/trust/cap_01M1A51TG1WX3T5NM8FPDHBZEF